US FDA approves ImmunityBio's bladder cancer therapy
The U.S. FDA had approved ImmunityBio's combination therapy to treat a type of bladder cancer, the company said on Monday.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- The U.S. FDA
- ImmunityBio
Advertisement